The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACER THERAPEUTICS INC | COM | 00444P108 | 1,385 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| ADMA BIOLOGICS INC | COM | 000899104 | 217 | 67,647 | SH | SOLE | 67,647 | 0 | 0 | ||
| ALIMERA SCIENCES INC | COM | 016259103 | 4,735 | 3,559,899 | SH | SOLE | 3,559,899 | 0 | 0 | ||
| MEDICREA INTERNATIONAL | COM | F6112U109 | 2,568 | 713,693 | SH | SOLE | 713,693 | 0 | 0 | ||
| AMARIN CORP PLC -ADR | SPONS ADR NEW | 023111206 | 70 | 17,533 | SH | SOLE | 17,533 | 0 | 0 | ||
| APOLLO ENDOSURGERY INC | COM | 03767D108 | 14,338 | 2,560,314 | SH | SOLE | 2,560,314 | 0 | 0 | ||
| AQUINOX PHARMACEUTICALS INC | COM | 03842B101 | 476 | 40,500 | SH | SOLE | 40,500 | 0 | 0 | ||
| BIODELIVERY SCIENCES INTL | COM | 09060J106 | 10,754 | 3,645,491 | SH | SOLE | 3,645,491 | 0 | 0 | ||
| BIOSPECIFICS TECHNOLOGIES | COM | 090931106 | 16,723 | 385,954 | SH | SOLE | 385,954 | 0 | 0 | ||
| CAREDX INC | COM | 14167L103 | 6,753 | 920,000 | SH | SOLE | 920,000 | 0 | 0 | ||
| CANCER GENETICS INC | COM | 13739U104 | 3,304 | 1,786,063 | SH | SOLE | 1,786,063 | 0 | 0 | ||
| CUMBERLAND PHARMACEUTICALS | COM | 230770109 | 9,619 | 1,306,911 | SH | SOLE | 1,306,911 | 0 | 0 | ||
| CARDIOME PHARMA CORP | COM NO PAR | 14159U301 | 4,953 | 3,195,692 | SH | SOLE | 3,195,692 | 0 | 0 | ||
| CTI BIOPHARMA CORP | COM NEW | 12648L601 | 4,917 | 1,834,838 | SH | SOLE | 1,834,838 | 0 | 0 | ||
| EIGER BIOPHARMACEUTICALS INC | COM | 28249U105 | 2,093 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 12,818 | 218,434 | SH | SOLE | 218,434 | 0 | 0 | ||
| NEOS THERAPEUTICS INC | COM | 64052L106 | 1,428 | 140,000 | SH | SOLE | 140,000 | 0 | 0 | ||
| NOVELION THERAPEUTICS INC | COM NEW | 67001K202 | 5,288 | 1,694,717 | SH | SOLE | 1,694,717 | 0 | 0 | ||
| OPHTHOTECH CORP | COM | 683745103 | 7,332 | 2,350,000 | SH | SOLE | 2,350,000 | 0 | 0 | ||
| RECRO PHARMA INC | COM | 75629F109 | 9,714 | 1,050,115 | SH | SOLE | 1,050,115 | 0 | 0 | ||
| STRONGBRIDGE BIOPHARMA PLC | SHS USD | G85347105 | 2,496 | 344,282 | SH | SOLE | 344,282 | 0 | 0 | ||
| STEADYMED LTD | SHS | M84920103 | 2,286 | 617,725 | SH | SOLE | 617,725 | 0 | 0 | ||
| VERACYTE INC | COM | 92337F107 | 8,066 | 1,235,147 | SH | SOLE | 1,235,147 | 0 | 0 | ||
| VICAL INC | COM NEW | 925602203 | 1,238 | 676,232 | SH | SOLE | 676,232 | 0 | 0 | ||
| VIVEVE MEDICAL INC | COM NEW | 92852W204 | 19,133 | 3,849,711 | SH | SOLE | 3,849,711 | 0 | 0 | ||
| VANDA PHARMACEUTICALS INC | COM | 921659108 | 13,452 | 885,000 | SH | SOLE | 885,000 | 0 | 0 | ||
| VERASTEM INC | COM | 92337C104 | 691 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||